AdipoLABs, ‘leading the way’ in practicing love for humanity around the world

Donated high-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ to Cambodia to treat COVID-19 and cancer patients.

CEO Han Sung-ho: “We will supply medical devices for cancer and virus patients in more countries.”

▲ AdipoLABs CEO Han Sung-ho (left) poses with Cambodian Minister of Agriculture Sakhon Veng at the donation ceremony.

【Health and Welfare News】 AdipoLABs (CEO Han Sung-ho), which independently develops, produces and sells ‘REMISSION 1℃’, a medical high-frequency hyperthermia cancer treatment device, is taking the lead in social responsibility and practicing love for humanity around the world.

In particular, as it became known that REMISSION 1℃ is effective in treating COVID-19, the device is attracting attention around the world. On the 2nd, AdipoLABs, together with Cambodian Minister of Agriculture Sakhon Veng and about 10 Cambodian government officials, participated in the donation ceremony that was held to donate REMISSION 1℃ to the Cambodian government for the treatment of COVID-19 and cancer patients.

REMISSION 1℃ was approved for cancer treatment by the Ministry of Food and Drug Safety in 2015, and is currently being used for cancer treatment in more than 100 hospitals in Korea, including Seoul St. Mary's Hospital and Severance Gangnam Hospital. Specifically, the equipment was used last year at Seosan Medical Center in South Chungcheong Province to treat patients infected with COVID-19. REMISSION 1℃ is a medical device that has been proven to dramatically increase immunity.

At the donation ceremony on this day, Cambodian Minister of Agriculture Sakhon Veng expressed his gratitude to Han Sung-ho, CEO of AdipoLABs, who responded to the donation, saying, “I hope this exchange will be a good opportunity to exchange medical technology and human resources between Korea and Cambodia.”

AdipoLABs CEO Han Sung-ho said, “If given the opportunity, we plan to supply medical devices to more countries for people suffering from cancer and pain viruses.”

AdipoLABs has currently donated REMISSION 1℃ free of charge to several countries, including Cameroon, Sri Lanka, and Uzbekistan, and is exporting to about 10 countries, including China, India, Malaysia, and Singapore.

In fact, ‘REMISSION 1℃’ is causing enormous attention for the treatment of COVID-19 with its immunotherapy device, and is working to provide overseas medical support as part of international medical sharing through IVRA.

Meanwhile, AdipoLABs' 'High Frequency Hyperthermia Device REMISSION 1℃' raises our body's temperature to over 40℃ through high frequency waves, increasing deep heat and causing necrosis of heat-vulnerable cancer cells while promoting blood circulation and activating autoimmune cells.

Based on this, the equipment was certified as an official medical device by the Ministry of Food and Drug Safety in 2015 as a device that not only treats cancer but also relieves pain, attracting the attention of major domestic and international exhibitions and medical officials.

In particular, when deep fever occurs through high frequency, the body's autoimmune cells, NK Cells, are activated to the highest level of the test value, and the medical staff observed these NK cells catching the virus. As a result of conducting clinical trials on COVID-19 patients in Korea, researchers were able to obtain a satisfying result.

Through REMISSION 1℃, AdipoLABs treats viral diseases by increasing the autoimmunity of COVID-19 patients. Researchers are willing to share treatment data between countries to speed up recovery to daily life even in the case of a different version of COVID-19 outbreak occurs in near future. REMISSION 1℃ can play a crucial role in preventing or suppressing the pandemic when it returns.

link : http://m.whosaeng.com/137892